American Vanguard Short Interest Rises 35% in March

Shares of the agricultural chemical company see increased short activity amid earnings miss.

Apr. 17, 2026 at 4:20pm

An extreme close-up of gears, levers, and other heavy industrial components that make up the inner workings of banking equipment, conveying the complex and powerful nature of financial institutions.The complex, interconnected machinery of the financial industry reflects the growing bearish sentiment around American Vanguard's stock performance.Newport Beach Today

American Vanguard Corporation (NYSE:AVD), a developer and marketer of specialty agricultural chemicals, saw a significant 35.3% increase in short interest during the month of March. As of March 31st, short interest totaled 949,010 shares, up from 701,243 shares on March 15th. The rise in short activity comes after the company reported weaker-than-expected Q1 earnings, with EPS missing consensus estimates.

Why it matters

The surge in short interest suggests investors are increasingly bearish on American Vanguard's near-term prospects, likely due to the company's recent earnings miss and broader concerns about the agricultural chemicals market. Short selling activity can provide insights into market sentiment and potential future stock price movements.

The details

American Vanguard reported Q1 2026 earnings of $0.06 per share, missing the consensus estimate of $0.28 per share. Revenue for the quarter was $150.69 million, below the expected $163 million. The company attributed the weaker results to a variety of factors, including increased competition and regulatory changes impacting some of its product lines.

  • As of March 31st, 2026, short interest in American Vanguard totaled 949,010 shares.
  • On March 15th, 2026, short interest was 701,243 shares.

The players

American Vanguard Corporation

A developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control, headquartered in Newport Beach, California.

Weiss Ratings

An independent investment research firm that recently reiterated a 'sell (e+)' rating on American Vanguard shares.

Got photos? Submit your photos here. ›

What’s next

Investors will be closely watching American Vanguard's next earnings report to see if the company can rebound from its Q1 miss and provide more clarity on the factors impacting its business.

The takeaway

The surge in short interest for American Vanguard highlights growing skepticism around the agricultural chemicals company's near-term performance, particularly after its recent earnings disappointment. However, the mixed analyst ratings suggest the stock's long-term outlook remains uncertain.